| Reference |
|---|
L xe1 szl xf3 L, Maczelka H, Tak xe1 cs T, Kurilla A, Tilajka x, Buday L, et al. A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System. Int J Mol Sci. 2022;23: pubmed publisher |
Kfoury Beaumont N, Prakasam R, Pondugula S, Lagas J, Matkovich S, Gontarz P, et al. The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential. BMC Biol. 2022;20:124 pubmed publisher |
Herzog A, Warner K, Zhang Z, Bellile E, Bhagat M, Castilho R, et al. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells. Cell Death Dis. 2021;12:988 pubmed publisher |
Pecce V, Verrienti A, Fiscon G, Sponziello M, Conte F, Abballe L, et al. The role of FOSL1 in stem-like cell reprogramming processes. Sci Rep. 2021;11:14677 pubmed publisher |
Strnadel J, Zahumenska R, Nosáľ V, Smolár M, Marcinek J, Kalman M, et al. Generation of ORIONi001-A induced pluripotent stem cell line for in vitro modeling of sporadic form of amyotrophic lateral sclerosis. Stem Cell Res. 2020;48:101981 pubmed publisher |
Guda M, Labak C, Omar S, Asuthkar S, Airala S, Tuszynski J, et al. GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets. Cancers (Basel). 2019;11: pubmed publisher |
Gambacurta A, Merlini G, Ruggiero C, Diedenhofen G, Battista N, Bari M, et al. Human osteogenic differentiation in Space: proteomic and epigenetic clues to better understand osteoporosis. Sci Rep. 2019;9:8343 pubmed publisher |
Solís Chagoyán H, Flores Soto E, Valdés Tovar M, Cercós M, Calixto E, Montaño L, et al. Purinergic Signaling Pathway in Human Olfactory Neuronal Precursor Cells. Stem Cells Int. 2019;2019:2728786 pubmed publisher |
Guda M, Asuthkar S, Labak C, Tsung A, Alexandrov I, Mackenzie M, et al. Targeting PDK4 inhibits breast cancer metabolism. Am J Cancer Res. 2018;8:1725-1738 pubmed |
Ravindran Menon D, Luo Y, Arcaroli J, Liu S, KrishnanKutty L, Osborne D, et al. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma. Cancer Res. 2018;: pubmed publisher |
Cortini M, Massa A, Avnet S, Bonuccelli G, Baldini N. Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion. PLoS ONE. 2016;11:e0166500 pubmed publisher |
Asuthkar S, Guda M, Martin S, Antony R, Fernandez K, Lin J, et al. Hand1 overexpression inhibits medulloblastoma metastasis. Biochem Biophys Res Commun. 2016;477:215-21 pubmed publisher |
Hamilton G, Hochmair M, Rath B, Klameth L, Zeillinger R. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Cell Adh Migr. 2016;10:360-7 pubmed publisher |
Valverde A, Peñarando J, Cañas A, López Sánchez L, Conde F, Hernández V, et al. Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells. PLoS ONE. 2015;10:e0131363 pubmed publisher |
Bobis Wozowicz S, Kmiotek K, Sekula M, Kedracka Krok S, Kamycka E, Adamiak M, et al. Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior. Stem Cells. 2015;33:2748-61 pubmed publisher |
James M, Howells L, Karmokar A, Higgins J, Greaves P, Cai H, et al. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note. PLoS ONE. 2015;10:e0117776 pubmed publisher |
Canham M, Charsou C, Stewart J, Moncur S, Hoodless L, Bhatia R, et al. Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease. PLoS ONE. 2014;9:e115379 pubmed publisher |
Labsch S, Liu L, Bauer N, Zhang Y, Aleksandrowicz E, Gladkich J, et al. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells. Int J Oncol. 2014;44:1470-80 pubmed publisher |
Liu L, Salnikov A, Bauer N, Aleksandrowicz E, Labsch S, Nwaeburu C, et al. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-?B downregulation. Int J Cancer. 2014;134:2489-503 pubmed |
Hage C, Rausch V, Giese N, Giese T, Schönsiegel F, Labsch S, et al. The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death Dis. 2013;4:e627 pubmed publisher |
Raynaud C, Halabi N, Elliott D, Pasquier J, Elefanty A, Stanley E, et al. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS ONE. 2013;8:e54524 pubmed publisher |
Ball S, Shuttleworth A, Kielty C. Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells. 2012;30:548-60 pubmed publisher |
Wortmann A, He Y, Christensen M, Linn M, Lumley J, Pollock P, et al. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734. J Biol Chem. 2011;286:42303-15 pubmed publisher |
Leis O, Eguiara A, López Arribillaga E, Alberdi M, Hernández García S, Elorriaga K, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 2012;31:1354-65 pubmed publisher |
